FROSINI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 4.652
AS - Asia 2.033
EU - Europa 1.930
SA - Sud America 369
AF - Africa 167
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.157
Nazione #
US - Stati Uniti d'America 4.530
SG - Singapore 717
IT - Italia 610
CN - Cina 562
HK - Hong Kong 425
BR - Brasile 308
SE - Svezia 306
DE - Germania 299
BG - Bulgaria 142
AT - Austria 129
GB - Regno Unito 124
VN - Vietnam 118
FI - Finlandia 76
CA - Canada 72
RU - Federazione Russa 71
CI - Costa d'Avorio 68
FR - Francia 53
IN - India 37
TR - Turchia 36
SN - Senegal 34
MX - Messico 31
NL - Olanda 26
PL - Polonia 25
AR - Argentina 23
ZA - Sudafrica 23
JP - Giappone 21
NG - Nigeria 20
BE - Belgio 17
ES - Italia 16
IQ - Iraq 15
BD - Bangladesh 14
ID - Indonesia 11
EC - Ecuador 10
UZ - Uzbekistan 10
KR - Corea 9
MA - Marocco 9
SA - Arabia Saudita 9
CO - Colombia 8
PK - Pakistan 8
LT - Lituania 7
CZ - Repubblica Ceca 6
PY - Paraguay 6
UA - Ucraina 6
JO - Giordania 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
CR - Costa Rica 4
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
MY - Malesia 4
PH - Filippine 4
AZ - Azerbaigian 3
EE - Estonia 3
PE - Perù 3
TW - Taiwan 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
EG - Egitto 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
KH - Cambogia 1
MK - Macedonia 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SO - Somalia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VI - Stati Uniti Isole Vergini 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.157
Città #
Ashburn 510
Woodbridge 469
Hong Kong 422
Fairfield 390
Singapore 384
Dallas 375
Santa Clara 299
Houston 281
Ann Arbor 274
Chandler 235
Seattle 182
Serra 178
Shanghai 162
Sofia 141
Cambridge 139
Wilmington 134
New York 125
Beijing 115
Vienna 112
Boardman 87
Frankfurt am Main 82
Los Angeles 78
Munich 78
Abidjan 68
Princeton 59
Pisa 55
Florence 54
Lawrence 52
Medford 48
Ottawa 43
Dearborn 42
Milan 40
Ho Chi Minh City 38
Turku 36
Dakar 34
Bremen 32
Des Moines 31
Lancaster 27
Istanbul 25
London 25
Buffalo 24
Lucca 24
Redondo Beach 24
Nanjing 23
São Paulo 21
San Diego 20
Lagos 19
Warsaw 19
Brussels 17
Ogden 17
Tokyo 17
Fuzhou 16
Council Bluffs 15
Dong Ket 15
Johannesburg 14
Mexico City 14
Rome 13
Brooklyn 12
Düsseldorf 11
Phoenix 11
Trieste 11
Denver 10
Nanchang 10
Norwalk 10
Toronto 10
Vicopisano 10
Chicago 9
Guangzhou 9
Helsinki 9
Poplar 9
Quanzhou 9
Shenyang 9
The Dalles 9
Columbus 8
Jinan 8
Montignoso 8
Stockholm 8
Tashkent 8
Baghdad 7
Belo Horizonte 7
Bologna 7
Chennai 7
Jacksonville 7
Montreal 7
Redwood City 7
Atlanta 6
Falls Church 6
Hebei 6
Hefei 6
Kunming 6
Newcastle upon Tyne 6
Nuremberg 6
Nürnberg 6
Orem 6
Portsmouth 6
San Jose 6
Amman 5
Brasília 5
Brno 5
Calgary 5
Totale 6.606
Nome #
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 257
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 209
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 203
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 196
High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis 195
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 194
Social Cognition and Oxytocin in Huntington’s Disease: New Insights 193
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 192
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 184
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 182
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease 180
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 175
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 174
Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases 172
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 171
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 169
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 166
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 160
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. 159
A semiautomatic tool for quantitative evaluation in 7T MR (magnetic resonance) images of the brain 158
Morphometric and functional MRI changes in essential tremor with and without resting tremore. 158
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 157
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study. 156
Mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines. 155
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 155
Quantitative susceptibility mapping in atypical Parkinsonisms 146
Symptomatic orthostatic tremor associated with Graves' disease. 145
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 144
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 143
Current treatment and future prospects of dopa-induced dyskinesias. 142
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 141
Dissecting the Interplay between Time of Dementia and Cognitive Profiles in Lewy Body Dementias 137
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 135
Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI 134
Semiautomated evaluation of the primary motor cortex in patients with amyotrophic lateral sclerosis at 3t 132
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 132
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 128
The hOGG1 Ser326Cys polymorphism is not associated with sporadic Parkinson's disease 127
Is DAT imaging abnormality in normal pressure hydrocephalus always suggestive of degeneration? 126
null 125
Midbrain MRI assessments in progressive supranuclear palsy subtypes 125
Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer’s Disease 124
Head tremor as a warning symptom of rapidly progressive syringomyelia: a case report 122
Impulsivity is associated with decision-making deficits in de-novo Parkinson's disease 121
Neuroimaging in Parkinsonʼs disease: focus on substantia nigra and nigro-striatal projection 117
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 110
Present and future of ultra-high field mri in neurodegenerative disorders 109
A molecular signature in blood identifies early Parkinsons disease 108
Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson's Disease 107
Theory of mind in Parkinson’s disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapy 106
Negative DAT-SPECT in Old Onset Parkinson's Disease: An Additional Pitfall? 105
null 103
Response 100
Sexual dysfunctions in Parkinson's disease: Review 100
MR imaging of the substantia nigra at 7 T enables diagnosis of parkinson disease 95
Semiautomatic image processing tool to measure small structures in magnetic resonance images of the brain at 7 Tesla application to hippocampus subfields of patients with mild cognitive impairment 91
null 89
null 88
Cerebello-thalamo-cortical network is intrinsically altered in essential tremor: evidence from a resting state functional MRI study 88
Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies 87
Statins in Parkinson's Disease: Influence on Motor Progression 86
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies 81
Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients 78
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms 78
Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay 64
Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies 61
null 61
The motor band sign differentiates hereditary spastic paraplegia from the others upper motor neuron syndromes 57
Nigral anatomy and striatal denervation in genetic Parkinsonism: A family report 54
Positive DAT-SCAN in SPG7: a case report mimicking possible MSA-C 48
Cerebello-thalamo-cortical network is intrinsically altered in essential tremor: evidence from a resting state functional MRI study 39
Totale 9.309
Categoria #
all - tutte 27.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021335 0 0 0 0 0 20 78 34 59 48 25 71
2021/2022659 13 25 9 43 132 85 21 37 52 27 41 174
2022/20231.043 102 139 102 77 103 121 8 74 226 9 69 13
2023/2024532 44 35 50 35 62 113 33 24 3 12 50 71
2024/20252.405 11 80 68 168 241 287 167 125 227 354 233 444
2025/20261.761 233 318 395 302 345 168 0 0 0 0 0 0
Totale 9.309